Overview
Hyeon-su Im practices practicing medicine in Ulsan, Republic of Korea.
Im is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Febrile Neutropenia, Agranulocytosis, Stomach Cancer, and Cholangiocarcinoma (Bile Duct Cancer).
They are actively involved in clinical research, co-authoring 29 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hyeon-su Im
Is Hyeon-su Im a top-rated expert for Febrile Neutropenia?
MediFind is an objective health platform that identifies experts based on real-world data. Hyeon-su Im is classified as an Advanced expert for Febrile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hyeon-su Im participate in research or clinical trials?
Yes. Hyeon-su Im has published 29 articles and abstracts on conditions like Febrile Neutropenia. You can view a list of Hyeon-su Im's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Febrile Neutropenia
- Experienced
- AgranulocytosisIm isExperienced. Learn about Agranulocytosis.
- Cholangiocarcinoma (Bile Duct Cancer)
- Stomach CancerIm isExperienced. Learn about Stomach Cancer.